USD 26.96
(2.78%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 60.43 Million USD | 22.77% |
2022 | 49.22 Million USD | -48.05% |
2021 | 94.76 Million USD | 15.19% |
2020 | 82.27 Million USD | 60.86% |
2019 | 51.14 Million USD | -73.92% |
2018 | 196.07 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 8.29 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 10.75 Million USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 13 Thousand USD | -99.99% |
2005 | 175.01 Million USD | -0.01% |
2004 | 175.02 Million USD | -0.06% |
2003 | 175.12 Million USD | -0.04% |
2002 | 175.18 Million USD | -9.02% |
2001 | 192.54 Million USD | 1046.03% |
2000 | 16.8 Million USD | 1192.38% |
1999 | 1.3 Million USD | 333.33% |
1998 | 300 Thousand USD | -50.0% |
1997 | 600 Thousand USD | -70.0% |
1996 | 2 Million USD | 25.0% |
1995 | 1.6 Million USD | -55.56% |
1994 | 3.6 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 71.39 Million USD | -3.75% |
2024 Q2 | 74.17 Million USD | 11.58% |
2024 Q1 | 66.47 Million USD | 10.0% |
2023 Q1 | 52.49 Million USD | 6.64% |
2023 Q4 | 60.43 Million USD | -2.21% |
2023 Q2 | 57.13 Million USD | 8.84% |
2023 Q3 | 61.79 Million USD | 8.16% |
2023 FY | 60.43 Million USD | 22.77% |
2022 Q4 | 49.22 Million USD | 5.37% |
2022 FY | 49.22 Million USD | -48.05% |
2022 Q1 | 93.5 Million USD | -1.33% |
2022 Q2 | 48.69 Million USD | -47.92% |
2022 Q3 | 46.71 Million USD | -4.06% |
2021 Q4 | 94.76 Million USD | 0.08% |
2021 Q1 | 84.21 Million USD | 2.37% |
2021 FY | 94.76 Million USD | 15.19% |
2021 Q2 | 82.81 Million USD | -1.66% |
2021 Q3 | 94.68 Million USD | 14.33% |
2020 Q1 | 71.27 Million USD | 39.35% |
2020 Q2 | 78.01 Million USD | 9.46% |
2020 Q3 | 79.67 Million USD | 2.13% |
2020 Q4 | 82.27 Million USD | 3.26% |
2020 FY | 82.27 Million USD | 60.86% |
2019 Q1 | 540.8 Million USD | 175.82% |
2019 Q4 | 51.14 Million USD | -90.55% |
2019 FY | 51.14 Million USD | -73.92% |
2019 Q3 | 541.07 Million USD | -0.45% |
2019 Q2 | 543.49 Million USD | 0.5% |
2018 Q1 | 197.26 Million USD | 0.0% |
2018 FY | 196.07 Million USD | 0.0% |
2018 Q4 | 196.07 Million USD | -0.2% |
2018 Q3 | 196.47 Million USD | -0.2% |
2018 Q2 | 196.87 Million USD | -0.2% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q1 | 8.17 Million USD | -1.46% |
2015 Q2 | 8.05 Million USD | -1.5% |
2015 Q3 | 7.93 Million USD | -1.54% |
2015 Q4 | - USD | -100.0% |
2015 FY | - USD | -100.0% |
2014 FY | 8.29 Million USD | 0.0% |
2014 Q4 | 8.29 Million USD | -1.43% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | 8.53 Million USD | 0.0% |
2014 Q3 | 8.41 Million USD | -1.39% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q1 | - USD | -100.0% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | -100.0% |
2010 Q2 | 11.09 Million USD | 0.0% |
2009 FY | 10.75 Million USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | 10.75 Million USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | 6000.00 USD | -64.71% |
2007 Q1 | 17 Thousand USD | 30.77% |
2007 FY | - USD | -100.0% |
2007 Q4 | - USD | -100.0% |
2007 Q3 | 4000.00 USD | -33.33% |
2006 Q4 | 13 Thousand USD | -99.99% |
2006 Q2 | 175.01 Million USD | 0.0% |
2006 Q1 | 175.01 Million USD | -0.0% |
2006 FY | 13 Thousand USD | -99.99% |
2006 Q3 | 175.02 Million USD | 0.01% |
2005 Q1 | 175.02 Million USD | -0.0% |
2005 Q2 | 175.01 Million USD | -0.01% |
2005 Q3 | 175.01 Million USD | 0.0% |
2005 FY | 175.01 Million USD | -0.01% |
2005 Q4 | 175.01 Million USD | -0.0% |
2004 Q2 | 175.06 Million USD | -0.02% |
2004 Q4 | 175.02 Million USD | -0.0% |
2004 Q3 | 175.02 Million USD | -0.02% |
2004 FY | 175.02 Million USD | -0.06% |
2004 Q1 | 175.09 Million USD | -0.02% |
2003 Q3 | 175.16 Million USD | -0.08% |
2003 FY | 175.12 Million USD | -0.04% |
2003 Q4 | 175.12 Million USD | -0.02% |
2003 Q2 | 175.3 Million USD | 0.09% |
2003 Q1 | 175.15 Million USD | -0.02% |
2002 Q2 | 194.89 Million USD | 0.0% |
2002 Q1 | 194.89 Million USD | 1.22% |
2002 Q3 | 192.64 Million USD | -1.15% |
2002 Q4 | 175.18 Million USD | -9.07% |
2002 FY | 175.18 Million USD | -9.02% |
2001 Q3 | 192.42 Million USD | 35800.19% |
2001 Q4 | 192.54 Million USD | 0.06% |
2001 Q2 | 536 Thousand USD | -96.78% |
2001 Q1 | 16.65 Million USD | -0.85% |
2001 FY | 192.54 Million USD | 1046.03% |
2000 Q2 | 17.07 Million USD | 1323.17% |
2000 FY | 16.8 Million USD | 1192.38% |
2000 Q1 | 1.2 Million USD | -7.69% |
2000 Q4 | 16.8 Million USD | -2.19% |
2000 Q3 | 17.17 Million USD | 0.59% |
1999 Q2 | - USD | 0.0% |
1999 Q1 | - USD | -100.0% |
1999 FY | 1.3 Million USD | 333.33% |
1999 Q4 | 1.3 Million USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 Q4 | 300 Thousand USD | 50.0% |
1998 Q1 | 400 Thousand USD | -33.33% |
1998 FY | 300 Thousand USD | -50.0% |
1998 Q2 | 300 Thousand USD | -25.0% |
1998 Q3 | 200 Thousand USD | -33.33% |
1997 Q3 | 11.5 Million USD | 64.29% |
1997 Q2 | 7 Million USD | 94.44% |
1997 FY | 600 Thousand USD | -70.0% |
1997 Q1 | 3.6 Million USD | 80.0% |
1997 Q4 | 600 Thousand USD | -94.78% |
1996 FY | 2 Million USD | 25.0% |
1996 Q2 | 2.6 Million USD | 0.0% |
1996 Q4 | 2 Million USD | -9.09% |
1996 Q3 | 2.2 Million USD | -15.38% |
1995 Q4 | 1.6 Million USD | 0.0% |
1995 FY | 1.6 Million USD | -55.56% |
1994 FY | 3.6 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | 29.485% |
AngioDynamics, Inc. | 5.91 Million USD | -921.914% |
AtriCure, Inc. | 74.49 Million USD | 18.871% |
Avinger, Inc. | 15.39 Million USD | -292.569% |
BioLife Solutions, Inc. | 42.69 Million USD | -41.566% |
The Cooper Companies, Inc. | 2.56 Billion USD | 97.648% |
Daxor Corporation | 755.65 Thousand USD | -7897.787% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -743.136% |
Femasys Inc. | 6.7 Million USD | -801.911% |
GlucoTrack, Inc. | 196 Thousand USD | -30734.694% |
Harvard Bioscience, Inc. | 42.77 Million USD | -41.295% |
Hologic, Inc. | 2.53 Billion USD | 97.616% |
ICU Medical, Inc. | 1.7 Billion USD | 96.455% |
Intuitive Surgical, Inc. | 89.8 Million USD | 32.699% |
KORU Medical Systems, Inc. | 4.44 Million USD | -1259.603% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -216.502% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 93.769% |
Microbot Medical Inc. | 231 Thousand USD | -26062.771% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -724.375% |
Merit Medical Systems, Inc. | 891.35 Million USD | 93.22% |
Nephros, Inc. | 1.83 Million USD | -3191.721% |
NovoCure Limited | 596.24 Million USD | 89.864% |
NEXGEL, Inc. | 2.79 Million USD | -2059.971% |
NEXGEL, Inc. | 2.79 Million USD | -2059.971% |
Singular Genomics Systems, Inc. | 75.28 Million USD | 19.727% |
OraSure Technologies, Inc. | 13.5 Million USD | -347.541% |
Pro-Dex, Inc. | 13.54 Million USD | -346.121% |
Pulse Biosciences, Inc. | 9.14 Million USD | -560.936% |
Predictive Oncology Inc. | 2.85 Million USD | -2015.503% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -1659.694% |
QuidelOrtho Corporation | 2.61 Billion USD | 97.688% |
Repligen Corporation | 711.8 Million USD | 91.509% |
Sanara MedTech Inc. | 11.79 Million USD | -412.512% |
STAAR Surgical Company | 35.83 Million USD | -68.655% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -17571.345% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 97.371% |
Jin Medical International Ltd. | 4.11 Million USD | -1369.39% |